Form 8-K - Current report:
SEC Accession No. 0001193125-11-115399
Filing Date
2011-04-28
Accepted
2011-04-28 16:49:23
Documents
9
Period of Report
2011-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 43572
2 SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 349382
3 FORM OF SENIOR SECURED CONVERTIBLE NOTE DUE 2021 dex102.htm EX-10.2 142461
4 SECURITY AGREEMENT dex103.htm EX-10.3 148909
5 SECOND AMENDMENT TO LEASE dex104.htm EX-10.4 24689
6 MANAGEMENT RETENTION AGREEMENT, DATED AS OF APRIL 25, 2011 - JOHN B. WHELAN dex105.htm EX-10.5 38487
7 MANAGEMENT RETENTION AGREEMENT, DATED AS OF APRIL 25, 2011 - MICHAEL A. ADAM dex106.htm EX-10.6 38596
8 PRESS RELEASE dex991.htm EX-99.1 13805
9 GRAPHIC g176826ex99_1.jpg GRAPHIC 10591
  Complete submission text file 0001193125-11-115399.txt   816195
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 11789196
SIC: 2834 Pharmaceutical Preparations